Articles

The benefits of B cells

Multiple studies point to B cells’ role in promoting anti-tumor immunity
Written byMel J. Yeates
| 4 min read

HOUSTON—According to researchers at The University of Texas MD Anderson Cancer Center, the likelihood of a patient responding to immune checkpoint blockade may depend on B cells in the tumor, located within specialized immune cell clusters known as tertiary lymphoid structures (TLS). Recent studies published in Nature have concluded that enrichment of B cells in TLS was predictive of response to checkpoint blockade in patients with melanoma, renal cell carcinomas (RCC) and soft-tissue sarcomas.

The studies conclude that the presence of B cells and their location within TLS, which act as a lymph node within the tumor, is critical for response to checkpoint blockade. This suggests a dynamic interaction between several immune system components.

One MD Anderson-led study found that B-cell markers were the most differentially expressed genes in responders relative to non-responders, and B cells in the tumors of responders appeared to be more mature and specialized.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gloved hand holding a multiwell cell culture plate under a fluorescence microscope for spheroid analysis.
Using confocal live-cell imaging to characterize immune-mediated cytotoxicity over time.
Fluorescence microscopy image of cells displaying green and red fluorescent signals.
Using confocal live-cell imaging to assess treatment effects in spheroids, organoids, and co-cultures.
3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.